On this page
Oculocutaneous albinism type 2
OCA2 leads to lighter skin and hair colour, along with specific visual impairments. It is an inherited condition present from birth and affects individuals worldwide.
Available at Jeen Health
Clinical tests that include this
Overview
Oculocutaneous albinism type 2 (OCA2) is a form of albinism, a group of inherited conditions that result in reduced or absent pigmentation (colour) in the skin, hair, and eyes [PMID:17950705]. This reduction in melanin, the pigment responsible for colour, leads to lighter complexion and hair, along with various vision problems. OCA2 is one of the more common types of oculocutaneous albinism, with a prevalence estimated at around 1 in 36,000 individuals in some populations. The condition is present from birth and affects both males and females equally. While albinism is often associated with very pale features, the degree of pigmentation reduction in OCA2 can vary, sometimes making it less immediately obvious than other forms of albinism.
Symptoms & clinical features
Individuals with OCA2 typically have hair colour ranging from light yellow to light brown, and their skin colour can be creamy white. Eye colour usually ranges from blue to grey or light brown. Unlike some other forms of albinism, people with OCA2 may have a subtle ability to produce some melanin over time, leading to slight darkening of hair and skin with age or sun exposure [PMID:19400206].
Visual problems are a key feature of OCA2 due to the role of melanin in eye development and function. These can include reduced sharpness of vision (visual acuity), involuntary rapid eye movements (nystagmus), sensitivity to light (photophobia), and a condition where the eyes do not look in the same direction (strabismus). The iris, the coloured part of the eye, may appear translucent when examined by a doctor.
Video: Genetics 101
Affected organs
The primary organs affected by oculocutaneous albinism type 2 are the skin, hair, and eyes. The reduction in melanin directly impacts the pigmentation of these tissues.
In the eyes, the lack of melanin affects the development of the retina and optic nerves, which are crucial for clear vision. This disruption contributes to the visual impairments experienced by individuals with OCA2, such as reduced visual acuity and nystagmus.
Risks & severity
The severity of pigmentation reduction in OCA2 can vary, with some individuals having very light features and others showing slightly more pigment. The visual impairments associated with OCA2 are generally stable over time and can range from mild to moderate. While vision may be significantly affected, individuals typically do not experience complete blindness.
Due to reduced skin pigmentation, individuals with OCA2 have an increased susceptibility to sun damage, including severe sunburns and a higher risk of developing skin cancers, such as basal cell carcinoma and squamous cell carcinoma. Regular skin checks and strict sun protection are therefore important throughout life.
Genetic causes
Oculocutaneous albinism type 2 is caused by genetic changes (variants) in the OCA2 gene. This gene provides instructions for making the OCA2 protein, also known as the P protein, which is found in melanosomes. Melanosomes are specialised compartments within cells where melanin, the pigment that gives colour to skin, hair, and eyes, is produced and stored [PMID:19400206].
The OCA2 protein is thought to play a role in regulating the pH of melanosomes, which is important for the function of other enzymes involved in melanin synthesis. Pathogenic variants in the OCA2 gene disrupt the normal function of this protein, leading to a reduced or abnormal production of melanin. This reduction in pigment is what gives rise to the characteristic features of OCA2.
- OCA2 OCA2 melanosomal transmembrane proteinThe OCA2 gene provides instructions for producing the P protein, which is essential for melanin synthesis and pigmentation of the skin, hair, and eyes.
Inheritance pattern
OCA2 is inherited in an autosomal recessive pattern. This means that a person must inherit two altered copies of the OCA2 gene - one from each parent - to develop the condition.
Parents who each carry one altered copy of the OCA2 gene are known as carriers. Carriers typically do not show symptoms of OCA2 themselves because they have one working copy of the gene, which is usually sufficient to produce enough melanin. When two carriers have children, there is a 25% chance with each pregnancy that the child will inherit two altered copies of the gene and develop OCA2. There is a 50% chance the child will be a carrier, and a 25% chance the child will inherit two working copies of the gene and not be affected or a carrier.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
A diagnosis of oculocutaneous albinism type 2 is often suspected based on the characteristic clinical features, including reduced pigmentation of the skin, hair, and eyes, along with specific visual problems. An ophthalmologist (eye specialist) can conduct tests to assess visual acuity, check for nystagmus, and examine the retina.
Confirmation of OCA2 is achieved through genetic testing. This involves analysing a blood sample to identify pathogenic variants in the OCA2 gene. In the UK, genetic testing for inherited conditions like OCA2 is typically coordinated through NHS Genomic Medicine Service (GMS) pathways. A referral to a clinical genetics service is usually required, often from a GP or an eye specialist. The relevant NHS Genomic Test Directory R-code for inherited disorders of pigmentation, including albinism, would be used to guide testing.
Management & lifestyle
While there is currently no cure for OCA2, management focuses on addressing the symptoms and reducing associated risks. Regular ophthalmological evaluations are important to monitor vision and provide appropriate optical aids, such as glasses or contact lenses, and low vision aids if required. Some individuals may benefit from tinted lenses to help with light sensitivity.
Skin protection is crucial for individuals with OCA2 due to the increased risk of sun damage and skin cancer. This includes consistently applying high-factor sunscreen, wearing protective clothing, and avoiding prolonged sun exposure, especially during peak hours. Regular skin checks by a dermatologist are also recommended. Genetic counselling can provide individuals and families with information about the condition, its inheritance pattern, and support in understanding the implications for family planning.
UK care pathway
In the UK, individuals suspected of having a genetic condition like OCA2 would typically be referred by their GP or another specialist (e.g., an ophthalmologist or dermatologist) to a regional NHS Clinical Genetics service. These services provide specialist assessment, genetic counselling, and access to diagnostic genetic testing through the NHS Genomic Medicine Service. The testing is guided by the National Genomic Test Directory, which specifies relevant R-codes for conditions like inherited disorders of pigmentation. Genetic counsellors play a vital role in explaining inheritance patterns, test results, and potential implications for family members.
Frequently asked questions
Can people with OCA2 go out in the sun?
Yes, but they need to take significant precautions. Due to reduced melanin, their skin is very sensitive to sunlight, increasing the risk of sunburn and skin cancer. High-factor sunscreen, protective clothing, and avoiding peak sun hours are strongly recommended.
Will my vision get worse over time with OCA2?
The visual impairments associated with OCA2 are generally present from birth and tend to be stable throughout life, rather than progressively worsening. Regular eye checks are still important to manage symptoms and ensure appropriate support.
Is there a cure for OCA2?
Currently, there is no cure for OCA2. Management focuses on addressing the symptoms, particularly visual impairments with corrective lenses, and protecting the skin from sun damage to prevent complications.
If I have OCA2, what are the chances my children will also have it?
OCA2 is inherited in an autosomal recessive manner. If you have OCA2, you will pass one altered copy of the OCA2 gene to all your children. For your children to also have OCA2, your partner would also need to be a carrier of an altered OCA2 gene or have OCA2 themselves.
What does the OCA2 gene do?
The OCA2 gene provides instructions for making a protein that is important for producing melanin, the pigment that gives colour to your skin, hair, and eyes. When the OCA2 gene has changes, it disrupts melanin production, leading to the features of OCA2.
References
- Chen C, Li J, Wang B. Clinical Manifestations and Genetic Spectrum of Oculocutaneous Albinism Type 2 in Chinese Patients. Genes. 2026. PMID: 42195040
- Adam MP, Bick S, Mirzaa GM. Oculocutaneous Albinism Type 2 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 1993. PMID: 20301410
- Aquaron R, Lasseaux E, Kelekele J. Co-occurrence of oculocutaneous albinism type 2 and mild sickle cell disease explained by HbS/βthal genotype in an individual from the Democratic Republic of Congo. European journal of medical genetics. 2022. PMID: 35964929
- Brilliant MH. The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment cell research. 2001. PMID: 11310796
- Aquaron R, Soufir N, Bergé-Lefranc JL. Oculocutaneous albinism type 2 (OCA2) with homozygous 2.7-kb deletion of the P gene and sickle cell disease in a Cameroonian family. Identification of a common TAG haplotype in the mutated P gene. Journal of human genetics. 2007. PMID: 17767372
- Neissi M, Al-Mozani SK, Al-Zaalan AR. Oculocutaneous albinism in a patient with an OCA2 variant: molecular and clinical insights. Asian biomedicine : research, reviews and news. 2025. PMID: 40735666
- Wang X, Zhu Y, Shen N. Mutational analysis of a Chinese family with oculocutaneous albinism type 2. Oncotarget. 2017. PMID: 29050284
- Chen X, Fang Z, Pang T. Identification of novel variations of oculocutaneous albinism type 2 with Prader-Willi syndrome/Angelman syndrome in two Chinese families. Frontiers in genetics. 2023. PMID: 36950135